ArticleMarine drugs2021
Seaweed Blends as a Valuable Source of Polyunsaturated and Healthy Fats for Nutritional and Food Applications.
Article in Marine drugs, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Night-Time Biomass and Compositional Dynamics inBiotech (Basel (Switzerland)) · 2026Article
- Unveiling the dual potential of microalgae and seaweed biomass for sustainable biofuel production: a review.RSC advances · 2025Review
- Fatty Acid Profile in Field-Collected Seaweed, Lipid Extraction Optimization, and Food Functional Properties.Life (Basel, Switzerland) · 2025Article
- Comparative evaluation of the flavor characteristics and nutritional value of different varieties ofFood chemistry: X · 2025Article
- Fatty Acid Content and Profile inLife (Basel, Switzerland) · 2025Article
- Detailed lipid investigation of edible seaweeds by photochemical derivatization and untargeted lipidomics.Analytical and bioanalytical chemistry · 2024Article
- Review
- Lipidomic Characterization and Antioxidant Activity of Macro- and Microalgae Blend.Life (Basel, Switzerland) · 2023Article
- Analysis of Antioxidant Lipids in Five Species of Dietary Seaweeds by Liquid Chromatography/Mass Spectrometry.Antioxidants (Basel, Switzerland) · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Seaweeds are considered healthy and sustainable food. Although their consumption is modest in Western countries, the demand for seaweed in food markets is increasing in Europe. Each seaweed species has unique nutritional and functional features. The preparation of blends, obtained by mixing several seaweeds species, allows the obtaining of maximum benefits and ingredients with single characteristics. In this work, five seaweed blends, commercially available and produced under organic conditions in Europe, were characterized. The proximal composition included contents of ash (20.28-28.68% DW), proteins (17.79-26.61% DW), lipids (0.55-1.50% DW), and total carbohydrates (39.47-47.37% DW). Fatty acid profiles were determined by gas chromatography-mass spectrometry (GC-MS), allowing quantification of healthy fatty acids, namely
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.